Close Menu

NEW YORK (360Dx) – The stock prices of most diagnostic firms in the 360Dx Index saw an uptick last month compared to February with the index gaining 4 percent in March.

Despite the index's improvement, its monthly growth slowed in comparison to February when it was up nearly 8 percent, and January when it was up 12 percent.

The index outpaced the broader markets last month, however. The Dow Jones Industrial average was essentially flat month over month, while the Nasdaq Composite grew almost 3 percent, but the Nasdaq Biotech was down about 1 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.